To determine the role of EZH2 in endometrial cancer development, we created mice with simultaneous deletion of Ezh2 and Pten (Ptend/d; Ezh2d/d) or Pten only (Ptend/d) in the uterus using Cre-LoxP approach (Figure 1A). This evidence concerns the gene EZH2 and endometrial cancer.